Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current Assets:    
Cash and Cash Equivalents $ 9,244,570 $ 3,635,224
License and Grant Fees Receivable 602,000 37,349
Prepaid Expenses and Other Current Assets 360,305 464,981
Current Portion of Refundable Tax Credit Receivable 21,691 16,484
Total Current Assets 10,228,566 4,154,038
Property and Equipment, Net 24,431 38,040
Restricted Cash 45,000 45,000
Goodwill and In-Process R&D 5,438,210 5,438,210
Other Assets 323,206 55,314
Total Assets 16,059,413 9,730,602
Current Liabilities:    
Accounts Payable 658,615 1,412,128
Accrued Expenses 1,724,272 1,670,930
Deferred Revenue 10,254,600 4,225,000
Total Current Liabilities 12,637,487 7,308,058
Non-Current Liabilities:    
Contingent Consideration 1,210,000 1,210,000
Deferred Tax Liability 1,525,896 1,525,896
Long-Term Portion of Capital Lease Obligation 6,585 16,069
Total Non-Current Liabilities 2,742,481 2,751,965
Total Liabilities 15,379,968 10,060,023
Commitments and Contingencies (Note 9)
Stockholders’ Equity (Deficit):    
Preferred Stock, $0.01 par value: 9,995,828 shares authorized; 3,750 designated Series A, 0 shares issued and outstanding at September 30, 2017 and December 31, 2016; 10,000 designated Series B, 600 and 0 issued and outstanding at September 30, 2017 and December 31, 2016, respectively 6 0
Common Stock, $0.01 par value: 100,000,000 shares authorized; 17,204,778 and 10,130,883 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 172,048 101,309
Additional Paid-In Capital 89,366,634 78,106,645
Accumulated Deficit (88,985,623) (78,598,738)
Stockholder Note Receivable 0 (58,824)
Accumulated Other Comprehensive Income 126,380 120,187
Total Stockholders’ Equity (Deficit) 679,445 (329,421)
Total Liabilities and Stockholders’ Equity (Deficit) $ 16,059,413 $ 9,730,602